![]()
|
|
||||||||
J. Biol. Chem., Vol. 280, Issue 39, 33566-33572, September 30, 2005
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||




||
1
From the
Institute of Pharmacology and Toxicology, University of Zurich, 8057 Zurich, the ||Department of Chemistry and Applied Biosciences, Federal Institute of Technology (ETH), 8093 Zurich,
Neuroscience Research, Novartis Institutes for BioMedical Research, Novartis Pharma AG, 4002 Basel, and the ¶Pharmazentrum, University of Basel, Department of Clinical-Biological Sciences, Institute of Physiology, 4056 Basel, Switzerland
The metabotropic
-aminobutyric acid, type B (GABAB) receptors mediate the slow component of GABAergic transmission in the brain. Functional GABAB receptors are heterodimers of the two subunits GABAB1 and GABAB2, of which GABAB1 exists in two main isoforms, GABAB1a and GABAB1b. The significance of the structural heterogeneity of GABAB receptors, the mechanism leading to their differential targeting in neurons as well as the regulation of cell surface numbers of GABAB receptors, is poorly understood. To gain insights into these processes, we searched for proteins interacting with the C-terminal domain of GABAB2. Here, we showed that the transcription factor CCAAT/enhancer-binding protein (C/EBP) homologous protein (CHOP) directly interacts with GABAB receptors in a subtype-selective manner to regulate cell surface expression of GABAB1a/GABAB2 receptors upon co-expression in HEK 293 cells. The interaction of CHOP with GABAB1a/GABAB2 receptors resulted in their intracellular accumulation and in a reduced number of cell surface receptors. This regulation required the interaction of CHOP via two distinct domains with the heterodimeric receptor; its C-terminal leucine zipper associates with the leucine zipper present in the C-terminal domain of GABAB2, and its N-terminal domain associates with an as yet unidentified site on GABAB1a. In conclusion, the data indicated a subtype-selective regulation of cell surface receptors by interaction with the transcription factor CHOP.
Received for publication, March 30, 2005 , and in revised form, July 26, 2005.
* The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 To whom correspondence should be addressed: Institute of Pharmacology and Toxicology, University Zürich, Winterthurerstrasse.190, 8057 Zürich. Tel.: 41-44-635-5930; Fax: 41-44-635-6874; E-mail: benke{at}pharma.unizh.ch.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
M. M. Bonaventura, P. N. Catalano, A. Chamson-Reig, E. Arany, D. Hill, B. Bettler, F. Saravia, C. Libertun, and V. A. Lux-Lantos GABAB receptors and glucose homeostasis: evaluation in GABAB receptor knockout mice Am J Physiol Endocrinol Metab, January 1, 2008; 294(1): E157 - E167. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Grampp, K. Sauter, B. Markovic, and D. Benke {gamma}-Aminobutyric Acid Type B Receptors Are Constitutively Internalized via the Clathrin-dependent Pathway and Targeted to Lysosomes for Degradation J. Biol. Chem., August 17, 2007; 282(33): 24157 - 24165. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |